SecSonar.com

LENSAR, Inc. (LNSR)

LENSAR, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

LENSAR, Inc. (LNSR) is a Medical - Devices company based in US with a market capitalization of $70.9M. Revenue grew 9.2% year-over-year and free cash flow was negative at -$14.9M. This page tracks LNSR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 140 employees · IPO Oct 2, 2020

Valuation

Valuation & price

$5.54 · as of May 17, 2026 · -58.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$13.32$9.21$5.09Jul 25Dec 25Jul 26Jul 7, 25$12.84Jul 9, 25$13.22Jul 11, 25$13.03Jul 15, 25$12.90Jul 17, 25$13.19Jul 21, 25$13.32Jul 23, 25$13.16Jul 25, 25$13.05Jul 29, 25$13.10Jul 31, 25$12.89Aug 4, 25$12.94Aug 6, 25$13.03Aug 11, 25$13.03Aug 13, 25$12.76Aug 15, 25$12.65Aug 19, 25$12.50Aug 21, 25$12.47Aug 25, 25$12.66Aug 27, 25$12.19Aug 29, 25$12.28Sep 3, 25$12.04Sep 5, 25$12.17Sep 9, 25$12.20Sep 11, 25$12.13Sep 16, 25$12.35Sep 18, 25$12.40Sep 22, 25$12.71Sep 24, 25$12.14Sep 26, 25$12.35Sep 30, 25$12.35Oct 2, 25$12.43Oct 6, 25$12.08Oct 8, 25$12.18Oct 10, 25$11.89Oct 14, 25$11.98Oct 16, 25$11.82Oct 21, 25$12.26Oct 23, 25$11.98Oct 27, 25$11.86Oct 29, 25$11.90Oct 31, 25$12.30Nov 4, 25$12.16Nov 6, 25$11.44Nov 10, 25$10.17Nov 12, 25$10.41Nov 14, 25$10.11Nov 18, 25$9.97Nov 20, 25$9.70Nov 25, 25$10.02Nov 28, 25$10.18Dec 2, 25$10.27Dec 4, 25$11.39Dec 8, 25$11.19Dec 10, 25$11.55Dec 12, 25$11.51Dec 16, 25$12.06Dec 18, 25$12.01Dec 22, 25$12.05Dec 24, 25$12.01Dec 29, 25$11.85Jan 2, 26$11.61Jan 6, 26$11.45Jan 8, 26$11.67Jan 12, 26$11.54Jan 14, 26$11.87Jan 16, 26$11.90Jan 21, 26$12.31Jan 23, 26$12.51Jan 27, 26$12.48Jan 29, 26$12.30Feb 2, 26$12.72Feb 4, 26$12.21Feb 9, 26$12.39Feb 11, 26$12.42Feb 13, 26$12.23Feb 18, 26$11.32Feb 20, 26$11.69Feb 24, 26$11.95Feb 26, 26$11.86Mar 2, 26$11.99Mar 4, 26$12.19Mar 6, 26$11.80Mar 10, 26$11.69Mar 12, 26$11.68Mar 17, 26$6.89Mar 19, 26$6.11Mar 23, 26$6.07Mar 25, 26$5.58Mar 27, 26$6.07Mar 31, 26$5.96Apr 2, 26$6.06Apr 7, 26$5.63Apr 9, 26$5.46Apr 13, 26$5.92Apr 15, 26$6.25Apr 17, 26$5.93Apr 22, 26$5.44Apr 24, 26$5.09Apr 28, 26$5.35Apr 30, 26$5.23May 4, 26$5.56May 6, 26$5.39May 8, 26$5.64May 12, 26$5.88May 14, 26$5.83May 18, 26$5.63May 20, 26$5.88May 22, 26$6.09May 28, 26$6.00Jun 1, 26$5.67Jun 3, 26$5.74Jun 5, 26$5.60Jun 9, 26$5.69Jun 11, 26$5.82Jun 15, 26$5.72Jun 17, 26$6.26Jun 22, 26$5.66Jun 24, 26$6.06Jun 26, 26$5.63Jul 2, 26$6.40
$5.0952-week range$13.32
Loading valuation history…

Fundamentals

Key fundamentals

$70.9M

Market cap

9.2%

Revenue growth (YoY)

46.4%

Gross margin

-$14.9M

Free cash flow (USD)

-$15.2M

Net debt

Net cash position

3.8%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$24.4MFY 2019$30.5MFY 2020$26.4MFY 2021$34.5MFY 2022$35.4MFY 2023$42.2MFY 2024$53.5MFY 2025$58.4M
$24.4M$58.4M

Free cash flow by year

2018 → 2025

FY 2018$-5.1MFY 2019$-14.7MFY 2020$-14.2MFY 2021$-9.3MFY 2022$-15.0MFY 2023$-9.9MFY 2024$-2.4MFY 2025$-14.9M
-$5.1M-$14.9M

Gross margin by year

2021 → 2025

FY 202151.8%FY 202256.4%FY 202350.1%FY 202448.3%FY 202546.4%
51.8%46.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCFO AppointmentMay 29, 2026Filing
  • 8-K eventEarnings ReleaseMay 8, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • Annual report10-K FiledApr 30, 2026Filing
  • 8-K eventCFO ResignationApr 15, 2026Filing
  • 8-K eventEarnings ReleaseMar 31, 2026Filing
  • Annual report10-K FiledMar 31, 2026Filing

Questions

Frequently asked questions

What is LENSAR, Inc.'s market cap?

LENSAR, Inc. (LNSR) has a market capitalization of $70.9M.

What is LNSR's P/E ratio?

A meaningful P/E ratio is not available for LNSR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying LNSR stock?

SEC Form 4 filings show no open-market insider buys at LENSAR, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

LUNG

Pulmonx Corporation

$70M

MDAI

Spectral AI, Inc.

$67.8M

XTNT

Xtant Medical Holdings, Inc.

$65.3M

ECOR

electroCore, Inc.

$78.1M

BDMD

Baird Medical Investment Holdings Limited

$62.3M

SRTS

Sensus Healthcare, Inc.

$53.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.